Short-Term Tests Are Unable to Distinguish Between Human Carcinogens and Noncarcinogens

References

• Short-Term Tests for Chemical Carcinogens, HF Stich, RHC San. Springer-Verlag, New York 1981
   Google Scholar
• Short-Term Test Systems for Detecting Carcinogens, KH Norpoth, RC Garner. Springer-Verlag, New York 1980
   Google Scholar
• Evaluation of Short-Term Tests for Carcinogenicity, FJ De Serres, J Ashby. Elsevier, New York 1981
   Google Scholar
• The Predictive Value of Short-Term Screening Tests in Carcinogenicity Evaluation, GM Williams, R Kroes, HW Waaijer, KW Van de Poll. Elsevier, Amsterdam 1980
   Google Scholar
• Ames BN. Carcinogens are mutagens: Their detection and classification. Env Health Perspec 1973; 6: 115–118
   PubMedGoogle Scholar
• Ames BN, Lee FD, Durston WE. An improved bacterial test system for the detection and classification of mutagens and carcinogens. Proc Nad Acad Sci USA 1973; 70: 782–786
   PubMed Web of Science ®Google Scholar
• Ames BN, McCann I, Yamasaki E. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Muta Res 1975; 31: 347–363
   PubMed Web of Science ®Google Scholar
• McCann J, Choi E, Yamasaki E, Ames BN. Detection of carcinogens as mutagens in the Salmonella/microsome test: Assay of 300 chemicals: Discussion. Proc Natl Acad Sci USA 1975; 72: 5135–5139
   PubMed Web of Science ®Google Scholar
• Boveri T. The Origin of Malignant Tumors. Williams and Wilkins, Baltimore 1929
   Google Scholar
• Current Issues in Toxicology, HC Grice. Springer-Verlag, New York 1984
   Google Scholar
• Executive Office of the President. Chemical carcinogens: A review of the science and its associated principles. Fed Reg 1985; 50: 10372–10442
   Google Scholar
• Sobels FH. A comprehensive exercise in comparative mutagenesis with exciting outcome or how good are mutation assays in predicting carcinogens. Muta Res 1985; 147: 1–4
   PubMed Web of Science ®Google Scholar
• Rosenkranz HS. Whither genetic toxicology? Suggestions for preserving its continued vitality. Muta Res 1984; 130: 389–390
   PubMed Web of Science ®Google Scholar
• Tice RR. An overview of occupational studies directed at assessing genetic damage. Reproduction: The New Frontier in Occupational and Environmental Health Research, JE Lockey, GK Lemasters, WR Key, Jr. Liss, New York 1984; 439–474
   Google Scholar
• Albertini RJ. Use of human T-lymphocytes to monitor mutations in human populations. Toxicity Testing: New Approaches and Applications in Human Risk Assessment, AP Li. Raven Press, New York 1985; 51–66
   Google Scholar
• Butterworth BE. Measurement of chemically-induced DNA repair in rodent and human cells. Toxicity Testing: New Approaches and Applications in Human Risk Assessment, AP Li. Raven Press, New York 1985; 33–40
   Google Scholar
• McCormick JJ, Maher VM. Use of human cells in mutagenicity and carcinogenicity determination. Toxicity Testing New Approaches and Applications in Human Risk Assessment, AP Li. Raven Press, New York 1985; 17–32
   Google Scholar
• Legator MS, Ward JB. Genetic toxicology-relevant studies with animals and humans. Reproduction: The New Frontier in Occupational and Environmental Health, JE Lockey, GK Lemasters, WR Keye, Jr. Liss, New York 1984; 491–525
   Google Scholar
• Broyde S, Hingerty B. Conformations of DNA adducts with polycyclic aromatic carcinogens. Molecular Basis of Cancer, Part A. Macromolecular Structure, Carcinogens and Oncogenes, R Rein. Liss, New York 1985; 153–171
   Google Scholar
• Burdette WJ. The significance of mutation in relation to the origin of tumors: A review. Cancer Res 1955; 15: 201–226
   PubMed Web of Science ®Google Scholar
• Ludford RJ. Ninth Scientific Report of the Imperial Cancer Research Fund 1930; 121–147
   Google Scholar
• Hueper WC, Conway WD. Chemical Carcinogenesis and Cancers. Charles C Thomas, Springfield, IL 1964
   Google Scholar
• Holliday R. A new theory of carcinogenesis. Br J Cancer 1979; 40: 513–522
   PubMed Web of Science ®Google Scholar
• Rubin H. Is somatic mutation the major mechanism of malignant transformation. J Natl Cancer Inst 1980; 64: 995–1000
   PubMed Web of Science ®Google Scholar
• Weinstein IB. Molecular and cellular mechanisms of chemical carcinogens. Cancer and Chemotherapy, Introduction to Neoplasia and Anti-neoplastic Chemotherapy, S Crooke, A Prestayko. Academic Press, New York 1980; Vol. 1: 169–196
   Google Scholar
• Weinstein IB, Mufson RA, Lee LS. Membrane and other biochemical effects of the phorbol esters and their relevance to tumor promotion. Carcinogenesis: Fundamental Mechanisms and Environmental Effects, B Pullman, POP Ts'o, H Gelboin. Reidel, Dordrecht, Holland 1980; 543–563
   Google Scholar
• Weinstein IB. Current concepts and controversies in chemical carcinogenesis. J Supramol Struc Cell Biochem 1981; 17: 99–120
   PubMedGoogle Scholar
• Ashwood-Smith MJ. The genetic toxicology of aldrin and dieldrin. Muta Res 1981; 86: 137–154
   PubMed Web of Science ®Google Scholar
• Trosko JE. A new paradigm is needed in toxicology evaluation. Environ Mutagen 1984; 6: 767–769
   PubMedGoogle Scholar
• Trosko JE, Chang C-C. Adaptive and nonadaptive consequences of chemical inhibition of intercellular communication. Pharmacol Rev 1984; 36: 1375–1418
   Google Scholar
• Rinkus SJ, Legator MS. The need for both in vitro and in vivo systems in mutagenicity screening. Chemical Mutagens. Principles and Methods for Their Detection, FJ De Serres, R Hollaender. Plenum, New York 1980; Vol. 6: 365–473
   Google Scholar
• Waters MD, Garreth NE, Covone-de Serres CM. Genetic toxicology of 14 agents causally associated with cancer in humans. Mutation, Cancer and Malformation, EHY Chu, WM Generoso. Plenum, New York 1984; 625–687
   Google Scholar
• Shelby MD, Stasiewicz S. Chemicals showing no evidence of carcinogenicity in long-term, two species rodent studies: The need for short-term test data. Environ Mutagen 1984; 6: 871–878
   PubMedGoogle Scholar
• International Agency for Research on Cancer. Evaluation of the Carcinogenic Risk of Chemicals to Humans. IARC, Lyon 1972–1982; Vols. 1–28
   Google Scholar
• IARC. Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans. Suppl. 4. IARC, Lyon 1982
   Google Scholar
• Ashby J. Overview of study and test chemical activities. Evaluation of Short-Term Tests for Carcinogens, FJ De Serres, J Ashby. Elsevier/North-Holland, New York 1981; 112–171
   Google Scholar
• Heinze JE, Poulsen NK. The optimal design of batteries of short-term tests for detecting carcinogens. Muta Res 1983; 117: 259–269
   PubMed Web of Science ®Google Scholar
• Cooper JA, Saracci R, Cole P. Describing the validity of carcinogen screening tests. Br J Cancer 1979; 39: 87–89
   PubMed Web of Science ®Google Scholar
• McCann J, Choi E, Yamasaki E, Ames BN. Detection of carcinogens as mutagens in the Salmonella/microsome test: Assay of 300 chemicals: Discussion. Proc Natl Acad Sci USA 1975; 72: 5135–5139
   PubMed Web of Science ®Google Scholar
• Sugimura T, Sato S, Nagao M. Overlapping of carcinogens and mutagens. Fundamentals in Cancer Prevention, PN Magee, S Takayama, T Sugimura, T Matsushima. University Park Press, Baltimore, MD 1976; 191–215
   Google Scholar
• Purchase IFH, Longstaff E, Ashby J. An evaluation of 6 short-term tests for detecting organic chemical carcinogens. Br J Cancer 1978; 37: 873–903
   PubMed Web of Science ®Google Scholar
• Hsie AW, O'Neill JP, San Sebastian JR, Brimer PA. The CHO/HGPRT mutation assay: Progress with quantitative mutagenesis and mutagen screening. Banbury Report 2, Mammalian Cell Mutagenesis, The Maturation of Test Systems, AW Hsie, JP O'Neill, VK McElheny. Cold Spring Harpor Symp., New York 1979; 407–418
   Google Scholar
• Simmon VF. In vitro mutagenicity assays of chemical carcinogens and related compounds with Salmonella typhimurium. J Nad Cancer Inst 1979; 62: 893–899
   PubMed Web of Science ®Google Scholar
• Bartsch HC, Malaveille C, Camus AM. Validation and comparative studies on 180 chemicals with S. typhimurium strains and V79 Chinese Hamster cells in the presence of various metabolizing systems. Muta Res 1980; 76: 1–50
   PubMed Web of Science ®Google Scholar
• Kawachi T, Komatsu T, Kada T. Results of recent studies on the relevance of various short-term screening tests in Japan. The Predictive Value of Short-Term Screening Tests in Carcinogenicity Evaluation, GM Williams, R Kroes, HW Waaijers, KW Van de Poll. Elsevier, Amsterdam 1980; 253–267
   Google Scholar
• Pienta RJ. Transformation of Syrian hamster embryo cells by diverse chemicals and correlation with their reported carcinogenic and mutagenic activities. Chemical Mutagens, Principles and Methods for Their Detection, FJ De Serres, A Hollaender. Plenum Press, New York 1980; Vol. 6: 175–202
   Google Scholar
• Goldin A, Wood HB, Jr. Preclinical investigation of alkylating agents in cancer chemotherapy. Ann NY Acad Sci 1969; 163: 954–1005
   Web of Science ®Google Scholar
• Committee 17. Environmental mutagenic hazards. Mutagenicity screening is now both feasible and necessary for chemicals entering the environment. Science 1975; 187: 503–514
   PubMed Web of Science ®Google Scholar
• Green EL. Genetic effects of radiation on mammalian populations. Ann Rev Genet 1968; 2: 87–120
   Google Scholar
• Adler I-D. Comparison of types of chemically induced genetic changes in mammals. Muta Res 1983; 115: 293–321
   PubMed Web of Science ®Google Scholar
• Adler I-D. Male germ cell cytogenetics. Cytogenetic Assays of Environmental Mutagens, TC Hsu. Allanheld, Osmun, Totowa, NJ 1982; 249–276
   Google Scholar
• Generoso WM, Cain KT, Huff SW, Gosslee DG. Inducibility by chemical mutagens of heritable translocation in male and female germ cells of mice. Advances in Modem Toxicology, WG Flamm, MA Mehlman. Hemisphere, Washington 1978; 109–129
   Google Scholar
• Generoso WM, Cattanach B, Malashenko AM. Mutagenicity of selected chemicals in mammals: The heritable translocation test. Comparative Chemical Mutagenesis, FJ De Serres, MD Shelby, 1981; 23: 681–708, Environ Sci Res
   Google Scholar
• Selby PB, Nieman SL. Non-breeding-test methods for dominant skeletal mutations shown by ethylnitrosourea to be easily applicable to offspring examined in specific-locus experiments. Muta Res 1984; 127: 93–105
   PubMed Web of Science ®Google Scholar
• Lovell DP, Willis DB, Johnson FM. Lack of evidence for skeletal abnormalities in offspring of mice exposed to ethylnitrosourea. Proc Natl Acad Sci USA 1985; 82: 2852–2856
   PubMed Web of Science ®Google Scholar
• Rosenkranz HS, Mermelstein R. Mutagenicity and genotoxicity of nitroarenes. All nitro-containing chemicals were not created equal. Muta Res 1983; 114: 217–267
   PubMed Web of Science ®Google Scholar
• Rosenkranz HS, Klopman G, Chankong V. Prediction of environmental carcinogens: A strategy for the mid-1980′s. Environ Mutagen 1984; 6: 231–258
   PubMedGoogle Scholar
• Rosenkranz HS, Mitchell CS, Klopman G. Artificial intelligence and Bayesian decision theory in the prediction of chemical carcinogens. Muta Res 1985; 150: 1–11
   PubMed Web of Science ®Google Scholar
• Klopman G. Artificial intelligence approach to structure—activity studies. Computer automated structure evaluation of biological activity of organic molecules. J Am Chem Soc 1984; 106: 7315–7321
   Web of Science ®Google Scholar
• Klopman G, Namboodiri K, Kalos AN. Computer automated evaluation and prediction of the iball index of carcinogenicity of polycyclic aromatic hydrocarbons. Molecular Basis of Cancer, Part A, Macromolecular Structure, Carcinogens, and Oncogenes, R Rein. Liss, New York 1985; 287–298
   Google Scholar
• Rinkus SJ, Legator MS. The need for both in vitro and in vivo systems in mutagenicity screening. Chemical Mutagens. Principles and Methods for Their Detection, FJ De Serres, R. Hollaender. Plenum, New York 1980; vol. 6: 365–473
   Google Scholar
• Haseman JK. A reexamination of false-positive rates for carcinogenesis studies. Fund Appl Toxicol 1983; 3: 334–339
   PubMedGoogle Scholar
• Haseman JK. Statistical issues in the design, analysis, and interpretation of animal carcinogenicity studies. Environ Health Perspec 1984; 58: 385–392
   PubMed Web of Science ®Google Scholar
• Meyers DB, Young SS, Gries CL. Design of cancer assays for pharmaceutical agents. J Natl Cancer Inst 1985; 74: 1151
   PubMed Web of Science ®Google Scholar
• Committee 3. International Commission for Protection Against Environmental Mutagens and Carcinogens. Regulatory approaches to the control of environmental mutagens and carcinogens. Muta Res 1983; 114: 174–216
   Google Scholar
• Weinberg AM, Storer JB. Ambiguous carcinogens and their regulation. Risk Anal 1985; 5: 151–156
   PubMed Web of Science ®Google Scholar